| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:11:11 UTC |
|---|
| Update date | 2020-09-17 15:32:55 UTC |
|---|
| Primary ID | FDB014280 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Luteolin 7-glucoside |
|---|
| Description | Luteolin-7-O-glucoside, also known as 7-O-glucoluteolin or cinaroside, belongs to the class of organic compounds known as flavonoid O-glycosides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C7-position. glucoside. Because of the conjugation of glucose, Luteolin 7-O-glucoside is a moderately water-soluble compound. Luteolin 7-O-glucoside is found, on average, in a few different plants, spices and foods, such as Mexican oregano, anises, and wild celeries and in a lower concentration in lentils, and wild carrots. common buckwheats, corns, globe artichokes, roman camomiles, and orange mints. |
|---|
| CAS Number | 5373-11-5 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside | ChEBI | | 2-(3,4-Dihydroxyphenyl)-7-(beta-D-glucopyranosyloxy)-5-hydroxy-4H-1-benzopyran-4-one | ChEBI | | 7-Glucoluteolin | ChEBI | | 7-Glucosylluteolin | ChEBI | | 7-O-beta-D-Glucosyl-5,7,3',4'-tetrahydroxyflavone | ChEBI | | Cinaroside | ChEBI | | Cynaroside | ChEBI | | Luteolin 7-monoglucoside | ChEBI | | Luteolin 7-O-glucopyranoside | ChEBI | | Luteolin 7-O-glucoside | ChEBI | | Luteolin-7-glucoside | ChEBI | | Luteoloside | ChEBI | | 2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl b-D-glucopyranoside | Generator | | 2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl β-D-glucopyranoside | Generator | | 2-(3,4-Dihydroxyphenyl)-7-(b-D-glucopyranosyloxy)-5-hydroxy-4H-1-benzopyran-4-one | Generator | | 2-(3,4-Dihydroxyphenyl)-7-(β-D-glucopyranosyloxy)-5-hydroxy-4H-1-benzopyran-4-one | Generator | | 7-O-b-D-Glucosyl-5,7,3',4'-tetrahydroxyflavone | Generator | | 7-O-Β-D-glucosyl-5,7,3',4'-tetrahydroxyflavone | Generator | | Luteolin 7-glucoside | ChEBI | | Daphneflavonoloside | HMDB | | Flavopurposide | HMDB | | Glucoluteolin | HMDB | | Luteolin 7-O-beta-D-glucoside | HMDB | | Luteolin 7-O-b-D-glucoside | Generator | | Luteolin 7-O-β-D-glucoside | Generator | | Nephrocizin | MeSH | | Luteolin-7-O-monoglucoside | MeSH | | Luteolin-7-O-beta-D-glucopyranoside | MeSH | | Luteolin-7-beta-D-glucoside | MeSH | | 3',4',5,7-Tetrahydroxyflavone 7-beta-D-glucopyranoside | PhytoBank | | 3',4',5,7-Tetrahydroxyflavone 7-β-D-glucopyranoside | PhytoBank | | 3’,4’,5,7-Tetrahydroxyflavone 7-β-D-glucopyranoside | PhytoBank | | 3',4',5-Trihydroxyflavone 7-O-beta-D-glucopyranoside | PhytoBank | | 3',4',5-Trihydroxyflavone 7-O-β-D-glucopyranoside | PhytoBank | | 3’,4’,5-Trihydroxyflavone 7-O-β-D-glucopyranoside | PhytoBank | | 7-(beta-D-Glucosyloxy)-3',4',5-trihydroxyflavone | PhytoBank | | 7-(β-D-Glucosyloxy)-3',4',5-trihydroxyflavone | PhytoBank | | 7-(β-D-Glucosyloxy)-3’,4’,5-trihydroxyflavone | PhytoBank | | 7-O-beta-D-Glucosylluteolin | PhytoBank | | 7-O-β-D-Glucosylluteolin | PhytoBank | | Luteolin 7-O-beta-D-glucopyranoside | PhytoBank | | Luteolin 7-O-β-D-glucopyranoside | PhytoBank | | Luteolin 7-O-beta-glucopyranoside | PhytoBank | | Luteolin 7-O-β-glucopyranoside | PhytoBank | | Luteolin 7-O-beta-glucoside | PhytoBank | | Luteolin 7-O-β-glucoside | PhytoBank | | Luteolin 7-beta-D-glucoside | PhytoBank | | Luteolin 7-β-D-glucoside | PhytoBank | | 7-O-β-D-glucosyl-5,7,3',4'-tetrahydroxyflavone | Generator |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C21H20O11 |
|---|
| IUPAC name | 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one |
|---|
| InChI Identifier | InChI=1S/C21H20O11/c22-7-16-18(27)19(28)20(29)21(32-16)30-9-4-12(25)17-13(26)6-14(31-15(17)5-9)8-1-2-10(23)11(24)3-8/h1-6,16,18-25,27-29H,7H2/t16-,18-,19+,20-,21-/m1/s1 |
|---|
| InChI Key | PEFNSGRTCBGNAN-QNDFHXLGSA-N |
|---|
| Isomeric SMILES | OC[C@H]1O[C@@H](OC2=CC3=C(C(O)=C2)C(=O)C=C(O3)C2=CC=C(O)C(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O |
|---|
| Average Molecular Weight | 448.3769 |
|---|
| Monoisotopic Molecular Weight | 448.100561482 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as flavonoid-7-o-glycosides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C7-position. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Flavonoids |
|---|
| Sub Class | Flavonoid glycosides |
|---|
| Direct Parent | Flavonoid-7-O-glycosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Flavonoid-7-o-glycoside
- 3'-hydroxyflavonoid
- 4'-hydroxyflavonoid
- 5-hydroxyflavonoid
- Flavone
- Hydroxyflavonoid
- Phenolic glycoside
- Hexose monosaccharide
- Chromone
- Glycosyl compound
- O-glycosyl compound
- Benzopyran
- 1-benzopyran
- Catechol
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Pyranone
- Pyran
- Oxane
- Monocyclic benzene moiety
- Benzenoid
- Monosaccharide
- Heteroaromatic compound
- Vinylogous acid
- Secondary alcohol
- Organoheterocyclic compound
- Oxacycle
- Polyol
- Acetal
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Alcohol
- Primary alcohol
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Biological role: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Not Available | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 56.25%; H 4.50%; O 39.25% | DFC |
|---|
| Melting Point | Mp 256-258° (254°) | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | 398 (e 21000) (MeOH-NaOH) (Berdy) | DFC |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Luteolin 7-glucoside, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-001r-8934600000-7e7c6044b90fb9c11463 | Spectrum | | Predicted GC-MS | Luteolin 7-glucoside, 3 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0f72-4730119000-f82ba729f371b8abdbda | Spectrum | | Predicted GC-MS | Luteolin 7-glucoside, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-0002-0010900030-c10d893db863fa97d0a8 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-0002-0010900030-c10d893db863fa97d0a8 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - DI-ESI-qTof , Positive | splash10-000i-0090000000-f076599705f9f223d360 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - DI-ESI-qTof , Negative | splash10-000i-0090100000-fe6850abbcec4fe56dd9 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , negative | splash10-0012-0190500000-bcf45c556204b1713d58 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , negative | splash10-0002-0030900020-65868b413ea8969c4672 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , negative | splash10-0019-0090000000-0908e4e690a4acb6edfc | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , negative | splash10-0002-0000900000-f15806fb1fd62f75af54 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , negative | splash10-001a-0190400000-862638c136c541fb742b | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , negative | splash10-000i-0091000000-f63c0d3cebcf6fc2e507 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , negative | splash10-0002-0040900000-e3f9043e8fac7872cb66 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-000i-0090000000-1ff8e42522b8a1f6961a | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-000i-0090100000-cb0df3f467ea51e6ab18 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-000j-0090600000-8f1dad507334d836e2a8 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-000i-0190000000-e3aa1461dda1c7043d2d | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITTOF , positive | splash10-000i-0090000000-31bb8bd03bfd2eff538b | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Linear Ion Trap , positive | splash10-000i-0091100000-ea4c2b653cea6f474766 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , positive | splash10-000i-0090000000-8392154e4309f46037d5 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Negative | splash10-0019-0090000000-a15f658ade963370f0c3 | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000j-0190600000-49dfd37238ba14bc6c11 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-00kr-0190000000-8733c538660a8dd11d05 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-014i-1390000000-ceeece13914238abed46 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000b-1261900000-e1ec4112e692ec8fbbd6 | 2016-08-04 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-000i-1190100000-bcbf2a30e128889e8047 | 2016-08-04 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00ku-2190000000-954ea2eef82d3bedfb36 | 2016-08-04 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 4444241 |
|---|
| ChEMBL ID | CHEMBL233929 |
|---|
| KEGG Compound ID | C03951 |
|---|
| Pubchem Compound ID | 5280637 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | 245 |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB35588 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | HQG45-Z:JPC55-X |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | CINAROSIDE|CYANAROSIDE|LUTEOLIN-7-BETA-D-GLUCOPYRANOSIDE|LUTEOLIN-7-BETA-D-GLUCOSIDE|LUTEOLIN-7-O-BETA-GLUCOSIDE|LUTEOLIN-7-GLUCOSIDE|CYNAROSIDE|LUTEOLIN-7-O-GLUCOSIDE|LUTEOLIN-7-O-BETA-D-GLUCOSIDE |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00004266 |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Luteolin_7-glucoside |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Aldose reductase inhibitor | 48550 | An agent that blocks the activity of aldose reductase, an enzyme involved in glucose metabolism. It reduces oxidative stress and inflammation, commonly used in managing diabetic complications, such as neuropathy, nephropathy, and retinopathy. | DUKE | | Anti complementary | | A substance that diminishes or abolishes the action of a complement, playing a role in regulating the immune system. Therapeutically, it's used to prevent excessive inflammation and tissue damage. Key medical uses include treating autoimmune disorders, transplant rejection, and inflammatory diseases. | DUKE | | Anti dermatic | 50177 | An agent that reduces skin inflammation and allergic reactions, commonly used in managing dermatitis, eczema, and other skin disorders, providing relief from itching, redness, and irritation. | DUKE | | Anti-herpetic | 22587 | An agent that inhibits the replication of herpes viruses, reducing symptoms and severity of infections. Therapeutically, it is used to treat herpes simplex (HSV-1 and HSV-2) and varicella-zoster virus (VZV) infections, commonly used in managing genital herpes, cold sores, and shingles. | DUKE | | Anti hyperthyroid | 52217 | An agent that reduces thyroid hormone production, used to manage hyperthyroidism by decreasing thyroid-stimulating hormone (TSH) and thyroid hormone levels, commonly used to treat conditions such as Graves' disease and thyroid storm. | DUKE | | Anti-inflammatory | 35472 | An agent that reduces inflammation, playing a biological role in suppressing immune responses and therapeutic applications in managing pain, swelling, and redness. Key medical uses include treating arthritis, allergies, and autoimmune disorders, as well as relieving symptoms of conditions such as asthma and dermatitis. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti-viral | 22587 | An agent that inhibits the replication of viruses, playing a crucial role in preventing and treating viral infections. Therapeutically, anti-virals are used to manage diseases such as HIV, herpes, and influenza, reducing symptoms and slowing disease progression. Key medical uses include treating viral hepatitis, respiratory syncytial virus, and COVID-19. | DUKE | | Calcium antagonist | 48706 | A medication that blocks calcium ion entry into cells, reducing muscle contraction and vascular resistance. It treats hypertension, angina, and arrhythmias by dilating blood vessels and decreasing cardiac workload, commonly used in managing cardiovascular diseases. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Cholagogue | | An agent that stimulates the release of bile from the gallbladder, promoting digestion and relieving bile duct issues. Therapeutically, it aids in treating gallstones, jaundice, and liver disorders, while also supporting digestive health. | DUKE | | Deiodinase inhibitor | 23924 | An agent that blocks the activity of deiodinases, enzymes involved in thyroid hormone regulation. It reduces thyroid hormone conversion, commonly used in managing thyroid disorders, such as hyperthyroidism, and certain types of cancer, including thyroid cancer. | DUKE | | Hypocholesterolemic | | An agent that lowers cholesterol levels in the blood, playing a crucial role in preventing cardiovascular disease. Therapeutically, it is used to manage hyperlipidemia and reduce the risk of heart disease, with key medical applications including the treatment of high cholesterol, atherosclerosis, and coronary artery disease. | DUKE | | Insectiphile | 24852 | A venom-derived peptide with anti-inflammatory and antimicrobial properties, promoting wound healing and tissue repair. Therapeutically, it has applications in managing infections, reducing inflammation, and accelerating recovery. Key medical uses include wound care, infection control, and tissue regeneration. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Rothwell JA, Pérez-Jiménez J, Neveu V, Medina-Ramon A, M'Hiri N, Garcia Lobato P, Manach C, Knox K, Eisner R, Wishart D, Scalbert A. (2013) Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database, 10.1093/database/bat070. — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|